The diagnosis of obstetric antiphospholipid syndrome from ACR/EULAR classification criteria in 2023
10.3760/cma.j.cn431274-20240910-01395
- VernacularTitle:从2023年ACR/EULAR抗磷脂综合征分类标准再谈产科抗磷脂综合征诊断
- Author:
Chunmei ZHAO
1
;
Chenhong WANG
Author Information
1. 南方医科大学深圳医院风湿免疫科，深圳 518101
- Keywords:
Antiphospholipid syndrome;
Classification criteria;
Pregnancy
- From:
Journal of Chinese Physician
2024;26(11):1623-1626
- CountryChina
- Language:Chinese
-
Abstract:
Obstetric antiphospholipid syndrome (APS) is an autoimmune disease that leads to adverse pregnancy outcomes. In the past decade, the diagnosis and treatment of obstetric APS has been based on the Sapporo classification standard revised in 2006. Considering the limitations of this standard, the American College of Rheumatology (ACR) and the European League against Rheumatic Diseases (EULAR) developed a new APS classification standard in 2023. The new standard has high specificity, greatly reduces the misdiagnosis of obstetric APS, and provides clinical basis for further standardized treatment.
